Persistence Market Research Company
Enquire Now Report Sample

Neuropathic Pain Market Size, Share, Trends, Growth, and Regional Forecasts 2025 - 2032

Neuropathic Pain Market by Drug Class (Tricyclic Anti-Depressants, Anticonvulsants, SNRI's, Topical Anesthetics, Opioids, Others), by Indication, by Route of Administration, by Distribution Channel, and Regional Analysis for 2025 - 2032

Comprehensive Snapshot of Neuropathic Pain Market Research Report, Including Regional and Country Analysis in Brief.

ID: PMRREP4149

Format: PPT*, PDF, EXCEL

Last Updated: 10 July 2025

Industry: Healthcare

Number of Pages: 191

Persistence Market Research Report, Market Growth and Regional Outlook
Request Sample Request Customization
Buy Now

Table of Content

  1. Executive Summary
    1. Global Neuropathic Pain Market Snapshot, 2025 and 2032
    2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
    3. COVID-19 Impact Analysis
    4. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Disease Epidemiology
    2. Value Chain Analysis
    3. Technology Assessment
    4. Product Adoption / Usage Analysis
    5. Recent Product Approvals & Launches
    6. Key Market Players
    7. Regulatory Landscape
    8. PESTLE Analysis
    9. Porter’s Five Force Analysis
  4. Global Neuropathic Pain Market Outlook
    1. Key Highlights
      1. Market Size (US$ Bn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Bn) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2019-2023
      2. Current Market Size (US$ Bn) Analysis and Forecast, 2024-2032
    3. Global Neuropathic Pain Market Outlook: Drug Class
      1. Historical Market Size (US$ Bn) Analysis, By Drug Class, 2019-2023
      2. Current Market Size (US$ Bn) and Forecast Analysis, By Drug Class, 2024-2032
        1. Tricyclic Anti-Depressants
        2. Anticonvulsants
        3. SNRI's
        4. Topical Anesthetics
        5. Opioids
        6. Others
      3. Market Attractiveness Analysis: Drug Class
    4. Global Neuropathic Pain Market Outlook: Indication
      1. Historical Market Size (US$ Bn) Analysis, By Indication, 2019-2023
      2. Current Market Size (US$ Bn) and Forecast Analysis, By Indication, 2024-2032
        1. Diabetic Neuropathy
        2. Chemotherapy-Induced Peripheral Neuropathy (CIPN)
        3. Post-Herpetic Neuralgia (PHN)
        4. Trigeminal Neuralgia
        5. Spinal Cord Injury-Associated Neuropathy
        6. Phantom Limb Pain
        7. Multiple Sclerosis-Associated Neuropathy
        8. Others 
      3. Market Attractiveness Analysis: Indication
    5. Global Neuropathic Pain Market Outlook: Route of Administration
      1. Historical Market Size (US$ Bn) Analysis, By Route of Administration, 2019-2023
      2. Current Market Size (US$ Bn) and Forecast Analysis, By Route of Administration, 2024-2032
        1. Oral
        2. Topical
        3. Parenteral
      3. Market Attractiveness Analysis: Route of Administration
    6. Global Neuropathic Pain Market Outlook: Distribution Channel
      1. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2023
      2. Current Market Size (US$ Bn) and Forecast Analysis, By Distribution Channel, 2024-2032
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      3. Market Attractiveness Analysis: Distribution Channel
  5. Global Neuropathic Pain Market Outlook: Region
    1. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2023
    2. Current Market Size (US$ Bn) and Forecast Analysis, By Region, 2024-2032
      1. North America
      2. Latin America
      3. Europe
      4. East Asia
      5. South Asia and Oceania
      6. Middle East & Africa
    3. Market Attractiveness Analysis: Region
  6. North America Neuropathic Pain Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
      1. By Country
      2. By Drug Class
      3. By Indication
      4. By Route of Administration
      5. By Distribution Channel
    2. Current Market Size (US$ Bn) Analysis and Forecast by Country, 2024-2032
      1. U.S.
      2. Canada
    3. Current Market Size (US$ Bn) and Forecast Analysis, By Drug Class, 2024-2032
      1. Tricyclic Anti-Depressants
      2. Anticonvulsants
      3. SNRI's
      4. Topical Anesthetics
      5. Opioids
      6. Others
    4. Current Market Size (US$ Bn) and Forecast Analysis, By Indication, 2024-2032
      1. Diabetic Neuropathy
      2. Chemotherapy-Induced Peripheral Neuropathy (CIPN)
      3. Post-Herpetic Neuralgia (PHN)
      4. Trigeminal Neuralgia
      5. Spinal Cord Injury-Associated Neuropathy
      6. Phantom Limb Pain
      7. Multiple Sclerosis-Associated Neuropathy
      8. Others 
    5. Current Market Size (US$ Bn) and Forecast Analysis, By Route of Administration, 2024-2032
      1. Oral
      2. Topical
      3. Parenteral
    6. Current Market Size (US$ Bn) and Forecast Analysis, By Distribution Channel, 2024-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    7. Market Attractiveness Analysis
  7. Europe Neuropathic Pain Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
      1. By Country
      2. By Drug Class
      3. By Indication
      4. By Route of Administration
      5. By Distribution Channel
    2. Current Market Size (US$ Bn) Analysis and Forecast by Country, 2024-2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    3. Current Market Size (US$ Bn) and Forecast Analysis, By Drug Class, 2024-2032
      1. Tricyclic Anti-Depressants
      2. Anticonvulsants
      3. SNRI's
      4. Topical Anesthetics
      5. Opioids
      6. Others
    4. Current Market Size (US$ Bn) and Forecast Analysis, By Indication, 2024-2032
      1. Diabetic Neuropathy
      2. Chemotherapy-Induced Peripheral Neuropathy (CIPN)
      3. Post-Herpetic Neuralgia (PHN)
      4. Trigeminal Neuralgia
      5. Spinal Cord Injury-Associated Neuropathy
      6. Phantom Limb Pain
      7. Multiple Sclerosis-Associated Neuropathy
      8. Others 
    5. Current Market Size (US$ Bn) and Forecast Analysis, By Route of Administration, 2024-2032
      1. Oral
      2. Topical
      3. Parenteral
    6. Current Market Size (US$ Bn) and Forecast Analysis, By Distribution Channel, 2024-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    7. Market Attractiveness Analysis
  8. East Asia Neuropathic Pain Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
      1. By Country
      2. By Drug Class
      3. By Indication
      4. By Route of Administration
      5. By Distribution Channel
    2. Current Market Size (US$ Bn) Analysis and Forecast by Country, 2024-2032
      1. China
      2. Japan
      3. South Korea
    3. Current Market Size (US$ Bn) and Forecast Analysis, By Drug Class, 2024-2032
      1. Tricyclic Anti-Depressants
      2. Anticonvulsants
      3. SNRI's
      4. Topical Anesthetics
      5. Opioids
      6. Others
    4. Current Market Size (US$ Bn) and Forecast Analysis, By Indication, 2024-2032
      1. Diabetic Neuropathy
      2. Chemotherapy-Induced Peripheral Neuropathy (CIPN)
      3. Post-Herpetic Neuralgia (PHN)
      4. Trigeminal Neuralgia
      5. Spinal Cord Injury-Associated Neuropathy
      6. Phantom Limb Pain
      7. Multiple Sclerosis-Associated Neuropathy
      8. Others 
    5. Current Market Size (US$ Bn) and Forecast Analysis, By Route of Administration, 2024-2032
      1. Oral
      2. Topical
      3. Parenteral
    6. Current Market Size (US$ Bn) and Forecast Analysis, By Distribution Channel, 2024-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    7. Market Attractiveness Analysis
  9. South Asia & Oceania Neuropathic Pain Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
      1. By Country
      2. By Drug Class
      3. By Indication
      4. By Route of Administration
      5. By Distribution Channel
    2. Current Market Size (US$ Bn) Analysis and Forecast by Country, 2024-2032
      1. India
      2. Indonesia
      3. Thailand
      4. Singapore
      5. ANZ
      6. Rest of South Asia & Oceania
    3. Current Market Size (US$ Bn) and Forecast Analysis, By Drug Class, 2024-2032
      1. Tricyclic Anti-Depressants
      2. Anticonvulsants
      3. SNRI's
      4. Topical Anesthetics
      5. Opioids
      6. Others
    4. Current Market Size (US$ Bn) and Forecast Analysis, By Indication, 2024-2032
      1. Diabetic Neuropathy
      2. Chemotherapy-Induced Peripheral Neuropathy (CIPN)
      3. Post-Herpetic Neuralgia (PHN)
      4. Trigeminal Neuralgia
      5. Spinal Cord Injury-Associated Neuropathy
      6. Phantom Limb Pain
      7. Multiple Sclerosis-Associated Neuropathy
      8. Others 
    5. Current Market Size (US$ Bn) and Forecast Analysis, By Route of Administration, 2024-2032
      1. Oral
      2. Topical
      3. Parenteral
    6. Current Market Size (US$ Bn) and Forecast Analysis, By Distribution Channel, 2024-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    7. Market Attractiveness Analysis
  10. Latin America Neuropathic Pain Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
      1. By Country
      2. By Drug Class
      3. By Indication
      4. By Route of Administration
      5. By Distribution Channel
    2. Current Market Size (US$ Bn) Analysis and Forecast by Country, 2024-2032
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    3. Current Market Size (US$ Bn) and Forecast Analysis, By Drug Class, 2024-2032
      1. Tricyclic Anti-Depressants
      2. Anticonvulsants
      3. SNRI's
      4. Topical Anesthetics
      5. Opioids
      6. Others
    4. Current Market Size (US$ Bn) and Forecast Analysis, By Indication, 2024-2032
      1. Diabetic Neuropathy
      2. Chemotherapy-Induced Peripheral Neuropathy (CIPN)
      3. Post-Herpetic Neuralgia (PHN)
      4. Trigeminal Neuralgia
      5. Spinal Cord Injury-Associated Neuropathy
      6. Phantom Limb Pain
      7. Multiple Sclerosis-Associated Neuropathy
      8. Others 
    5. Current Market Size (US$ Bn) and Forecast Analysis, By Route of Administration, 2024-2032
      1. Oral
      2. Topical
      3. Parenteral
    6. Current Market Size (US$ Bn) and Forecast Analysis, By Distribution Channel, 2024-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    7. Market Attractiveness Analysis
  11. Middle East & Africa Neuropathic Pain Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
      1. By Country
      2. By Drug Class
      3. By Indication
      4. By Route of Administration
      5. By Distribution Channel
    2. Current Market Size (US$ Bn) Analysis and Forecast by Country, 2024-2032
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    3. Current Market Size (US$ Bn) and Forecast Analysis, By Drug Class, 2024-2032
      1. Tricyclic Anti-Depressants
      2. Anticonvulsants
      3. SNRI's
      4. Topical Anesthetics
      5. Opioids
      6. Others
    4. Current Market Size (US$ Bn) and Forecast Analysis, By Indication, 2024-2032
      1. Diabetic Neuropathy
      2. Chemotherapy-Induced Peripheral Neuropathy (CIPN)
      3. Post-Herpetic Neuralgia (PHN)
      4. Trigeminal Neuralgia
      5. Spinal Cord Injury-Associated Neuropathy
      6. Phantom Limb Pain
      7. Multiple Sclerosis-Associated Neuropathy
      8. Others 
    5. Current Market Size (US$ Bn) and Forecast Analysis, By Route of Administration, 2024-2032
      1. Oral
      2. Topical
      3. Parenteral
    6. Current Market Size (US$ Bn) and Forecast Analysis, By Distribution Channel, 2024-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    7. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
      1. Competition Intensity Mapping by Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. Almatica
        1. Overview
        2. Segments and Sources
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Vertex Pharmaceuticals Incorporated
      3. Azurity Pharmaceuticals, Inc.
      4. Pfizer Inc.
      5. Viatris Inc.
      6. Supernus Pharmaceuticals, Inc.
      7. Novartis AG
      8. Accord Healthcare
      9. Focus Health Group
      10. ABneal Pharmaceuticals LLC.
      11. Abbott
      12. Teva Pharmaceutical Industries Ltd.
      13. Others
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations

Thank you for taking time to visit our website, click like if you found the information on this page useful?

View All Reports
Research Methodology
Contact Us
This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate